Insider Transactions in Q2 2021 at Zynex Inc (ZYXI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-34.17%
|
$112,000
$16.15 P/Share
|
|
Jun 11
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-42.27%
|
$240,000
$16.29 P/Share
|
|
Jun 10
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-7.8%
|
$48,000
$16.16 P/Share
|
|
Jun 07
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,314
-6.28%
|
$34,710
$15.75 P/Share
|
|
Jun 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.98%
|
-
|
|
May 05
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
701
+1.24%
|
-
|
|
May 05
2021
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,754
+50.0%
|
-
|
|
May 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
350
-1.01%
|
$4,900
$14.13 P/Share
|
|
May 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,754
+1.72%
|
-
|
|
May 04
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-0.55%
|
$2,618
$14.3 P/Share
|
|
Apr 27
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.33%
|
-
|
|
Apr 14
2021
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
438
-1.39%
|
-
|
|
Apr 14
2021
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
24,759
+22.97%
|
-
|
|
Apr 08
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,156
-3.35%
|
$17,340
$15.25 P/Share
|